Cargando…

Azapeptide activity-based probes for the SARS-CoV-2 main protease enable visualization of inhibition in infected cells

The COVID-19 pandemic has revealed the vulnerability of the modern, global society. With expected waves of future infections by SARS-CoV-2, treatment options for infected individuals will be crucial in order to decrease mortality and hospitalizations. The SARS-CoV-2 main protease is a validated drug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vanhoutte, Roeland, Barniol-Xicota, Marta, Chiu, Winston, Vangeel, Laura, Jochmans, Dirk, De Jonghe, Steven, Zidane, Hadeer, Barr, Haim M., London, Nir, Neyts, Johan, Verhelst, Steven H. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2023
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931053/ https://www.ncbi.nlm.nih.gov/pubmed/36819852 http://dx.doi.org/10.1039/d2sc04147b

Ejemplares similares

Lipidomic and in-gel analysis of maleic acid co-polymer nanodiscs reveals differences in composition of solubilized membranes
por: Barniol-Xicota, Marta, et al.
Publicado: (2021)

Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
por: Vangeel, Laura, et al.
Publicado: (2022)

Ivermectin Does Not Protect against SARS-CoV-2 Infection in the Syrian Hamster Model
por: Foo, Caroline S., et al.
Publicado: (2022)

Short Azapeptides of Folded Structures in Aqueous Solutions
por: Yan, Xiao-Sheng, et al.
Publicado: (2018)

Development of a robust and convenient dual-reporter high-throughput screening assay for SARS-CoV-2 antiviral drug discovery
por: Chiu, Winston, et al.
Publicado: (2023)

A SCID Mouse Model To Evaluate the Efficacy of Antivirals against SARS-CoV-2 Infection
por: Abdelnabi, Rana, et al.
Publicado: (2022)

Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase
por: Kasprzyk, Renata, et al.
Publicado: (2021)

Thiocarbazate building blocks enable the construction of azapeptides for rapid development of therapeutic candidates
por: Altiti, Ahmad, et al.
Publicado: (2022)

Diastereomeric Resolution Yields Highly Potent Inhibitor of SARS-CoV-2 Main Protease
por: Cooper, Mark S., et al.
Publicado: (2022)

Transmembrane Fluoride Transport by a Cyclic Azapeptide With Two β-Turns
por: Zhao, Zhixing, et al.
Publicado: (2021)

Synthesis, characterization, molecular docking, and anticancer activities of new 1,3,4-oxadiazole-5-fluorocytosine hybrid derivatives
por: El Mansouri, Az-eddine, et al.
Publicado: (2022)

Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
por: Luttens, Andreas, et al.
Publicado: (2022)

The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern
por: Abdelnabi, Rana, et al.
Publicado: (2022)

Synthesis and Biomedical Potential of Azapeptide Modulators of the Cluster of Differentiation 36 Receptor (CD36)
por: Proulx, Caroline, et al.
Publicado: (2020)

Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues
por: Persoons, Leentje, et al.
Publicado: (2021)

Computational Investigation of Conformational Properties of Short Azapeptides: Insights from DFT Study and NBO Analysis
por: El Khabchi, Mouna, et al.
Publicado: (2023)

A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents
por: Do, Thuc Nguyen Dan, et al.
Publicado: (2021)

Phosphinate esters as novel warheads for activity-based probes targeting serine proteases
por: Kahler, Jan Pascal, et al.
Publicado: (2021)

Synthesis and evaluation of 3-alkynyl-5-aryl-7-aza-indoles as broad-spectrum antiviral agents
por: Martinez-Gualda, Belén, et al.
Publicado: (2022)

Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors
por: Gao, Shenghua, et al.
Publicado: (2022)

The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor In Vitro and Confer Resistance To Nirmatrelvir
por: Jochmans, Dirk, et al.
Publicado: (2023)

Development and optimization of a high‐throughput screening assay for in vitro anti‐SARS‐CoV‐2 activity: Evaluation of 5676 Phase 1 Passed Structures
por: Chiu, Winston, et al.
Publicado: (2022)

Discovery of SARS-CoV-2 main protease inhibitors using a synthesis-directed de novo design model
por: Morris, Aaron, et al.
Publicado: (2021)

HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effect
por: Foo, Caroline S., et al.
Publicado: (2022)

Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity
por: Nizi, Maria Giulia, et al.
Publicado: (2022)

Cytopathic SARS-CoV-2 screening on VERO-E6 cells in a large-scale repurposing effort
por: Zaliani, Andrea, et al.
Publicado: (2022)

The path towards effective antivirals against rabies
por: Jochmans, Dirk, et al.
Publicado: (2019)

Novel Green Fluorescent Polyamines to Analyze ATP13A2 and ATP13A3 Activity in the Mammalian Polyamine Transport System
por: Houdou, Marine, et al.
Publicado: (2023)

In vitro activity of itraconazole against SARS‐CoV‐2
por: Van Damme, Ellen, et al.
Publicado: (2021)

ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model
por: Vandyck, Koen, et al.
Publicado: (2021)

Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters
por: Abdelnabi, Rana, et al.
Publicado: (2022)

A cyclic azapeptide ligand of the scavenger receptor CD36/SR-B2 reduces the atherosclerotic lesion progression and enhances plaque stability in apolipoprotein E-deficient mice
por: Gauvin, Jade, et al.
Publicado: (2023)

Intervention strategies for emerging viruses: use of antivirals
por: Debing, Yannick, et al.
Publicado: (2013)

A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE
por: Jochmans, Dirk, et al.
Publicado: (2012)

Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model
por: Abdelnabi, Rana, et al.
Publicado: (2021)

The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model
por: Abdelnabi, Rana, et al.
Publicado: (2021)

Norovirus: Targets and tools in antiviral drug discovery
por: Rocha-Pereira, Joana, et al.
Publicado: (2014)

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
por: Douangamath, Alice, et al.
Publicado: (2020)

A Structural Comparison of SARS-CoV-2 Main Protease and Animal Coronaviral Main Protease Reveals Species-Specific Ligand Binding and Dimerization Mechanism
por: Ho, Chien-Yi, et al.
Publicado: (2022)

A New Class of Rhomboid Protease Inhibitors Discovered by Activity-Based Fluorescence Polarization
por: Wolf, Eliane V., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6d72ha9d64fdru7rolkr19ubf1